Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1032

Introduced
2/5/25  

Caption

Stop Funding Our Adversaries Act of 2023

Impact

If enacted, this legislation would have substantial implications on federal research funding protocols. It would restrict federal agencies from engaging in cooperative agreements or grants that may fund Chinese-controlled research initiatives. This measure aligns with growing concerns regarding intellectual property theft and espionage associated with China, thereby reflecting a broader strategy to safeguard national interests. The bill may also affect existing collaborations between American institutions and Chinese entities, potentially stifling scientific progress in areas of mutual benefit if those initiatives involve federal funding.

Summary

House Bill 1032, also known as the 'Stop Funding Our Adversaries Act of 2023', seeks to prohibit any federal spending that supports research conducted in China. The bill is primarily concerned with national security implications arising from financial engagements with the Chinese government and its affiliated entities. By forbidding the Secretary of Defense, the Secretary of Veterans Affairs, and other federal agencies from directly or indirectly funding research in China, the bill aims to reduce potential risks associated with sharing sensitive technologies or information with adversarial states.

Contention

The key points of contention surrounding HB1032 revolve around the balance of security and collaboration in research. Proponents argue that it is crucial to prevent potential risks posed by adversarial countries while critics caution against overly restrictive measures that could hinder scientific innovation and global collaboration. While the bill targets funding directed at potential adversaries, this could have collateral effects on cooperative scientific efforts that could yield beneficial results for both American and global communities.

Congress_id

119-HR-1032

Introduced_date

2025-02-05

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.